Aptevo Therapeutics Inc. Business Finance Contracts & Agreements
40 Contracts & Agreements
- Contribution Agreements (1 contract)
- Credit Agreements (6)
- Equity Distribution Agreements (2)
- Note Agreements (1)
- Purchase Agreements (9)
- Registration Rights Agreements (5)
- Security Agreements (1)
- Stock Agreements (2)
- Underwriting Agreements (1)
- Warrant Agreements (12)
- Form of Warrant Inducement Agreement, by and between the Company and each Holder (Filed With SEC on November 9, 2023)
- Form of New Series B-2 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series B-1 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series A-2 Warrant (Filed With SEC on November 9, 2023)
- Form of New Series A-1 Warrant (Filed With SEC on November 9, 2023)
- Securities Purchase Agreement, dated August 1, 2023, between the Company and the purchasers party thereto (Filed With SEC on August 7, 2023)
- Pre-funded Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Series B Common Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Series A Common Warrant, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 14, 2023)
- Form of Common Warrant (Filed With SEC on July 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on July 14, 2023)
- Third Amendment to Credit and Security Agreement dated August 30, 2022 (Filed With SEC on November 10, 2022)
- Limited Consent and Second Amendment to Credit and Security Agreement dated June 7, 2022 (Filed With SEC on August 11, 2022)
- Amendment to Royalty Purchase Agreement dated June 7, 2022 (Filed With SEC on August 11, 2022)
- Agreement to Terminate Registration Rights Agreement between the Company and Intervac L.L.C. and BioVac L.L.C (Filed With SEC on March 24, 2022)
- Registration Rights Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
- Purchase Agreement, dated February 16, 2022, by and between the Company and Lincoln Park (Filed With SEC on February 17, 2022)
- Royalty Purchase Agreement by and among Aptevo Therapeutics Inc. and Healthcare Royalty Partners IV, LP. dated as of March 30, 2021 (Filed With SEC on May 11, 2021)
- Description of Capital Stock of Aptevo Therapeutics (Filed With SEC on March 31, 2021)
- Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co (Filed With SEC on December 14, 2020)
- Rights Agreement, dated as of November 8, 2020, by and between Aptevo Therapeutics Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent (Filed With SEC on November 9, 2020)
- LLC Purchase Agreement by and among Aptevo Therapeutics Inc. and Medexus Pharma, Inc. dated February 28, 2020 (Filed With SEC on March 2, 2020)
- Amendment to LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol... (Filed With SEC on August 9, 2019)
- Intellectual Property Security Agreement, dated February 7, 2019, by and amoung, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC., Aptevo Research and Development, LLC and... (Filed With SEC on March 18, 2019)
- Amendment No. 1 to Amended and Restated Credit and Security Agreement, dated December 14, 2018, by and among, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC, Aptevo Research... (Filed With SEC on March 18, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on March 11, 2019)
- Form of Warrant (Filed With SEC on March 11, 2019)
- Underwriting Agreement between Aptevo Therapeutics, Inc. and Piper Jaffray & Co., dated March 7, 2019 (Filed With SEC on March 11, 2019)
- Registration Rights Agreement between Aptevo Therapeutics Inc. and Lincoln Park Capital Fund, LLC, dated December 20, 2018 (Filed With SEC on December 24, 2018)
- Purchase Agreement between Aptevo Therapeutics Inc. and Lincoln Park Capital Fund, LLC, dated December 20, 2018 (Filed With SEC on December 24, 2018)
- Aptevo Therapeutics Inc. Non-Statutory Stock Option Agreement (Filed With SEC on August 9, 2018)
- Amendment No. 3 to Credit and Security Agreement, dated as of February 23, 2018, by and among Aptevo Therapeutics Inc. and certain of its subsidiaries and Midcap Financial Trust (Filed With SEC on March 13, 2018)
- LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol International... (Filed With SEC on November 13, 2017)
- Equity Distribution Agreement, dated November 9, 2017, between Aptevo Therapeutics Inc. and Piper Jaffray and Company, LLC (Filed With SEC on November 9, 2017)
- Amendment No. 2 to Credit and Security Agreement dated September 28, 2017 (Filed With SEC on September 29, 2017)
- amendment No. 1 to CREDIT AND SECURITY AGREEMENT (Filed With SEC on May 12, 2017)
- NON-NEGOTIABLE PROMISSORY NOTE (Filed With SEC on August 2, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 2, 2016)
- CONTRIBUTION AGREEMENT (Filed With SEC on August 2, 2016)
